Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 8, 2017Pharmacological ResearchOpen Access

The review summarizes current knowledge on AT2R regulation, signaling, and its protective effects in cardiovascular and renal diseases, highlighting AT2R agonists as attractive targets for drug development.

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Authors

EKElena KaschinaPNPawel NamsolleckTUThomas Unger

Discussion

Loading...

Member takes

Overview

AT2R agonists merit evaluation in cardiovascular and renal diseases; leaves open confirmation of efficacy in prospective trials.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kaschina et al. (2017) studied this question.

synapsesocial.com/papers/69d573009d980f6498ccb23fhttps://doi.org/10.1016/j.phrs.2017.07.008
View Full Paper
Ask AI
Bookmark
Share